Dr. Klein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8110 Birmingham Way
San Diego, CA 92123Phone+1 858-966-4032Fax+1 858-309-6301
Education & Training
- National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1988 - 1990
- Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1985 - 1988
- Pennsylvania State University College of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1993 - 2026
- DE State Medical License 1994 - 2003
- NJ State Medical License 1999 - 2001
- PA State Medical License 1986 - 2000
- MD State Medical License 1988 - 1999
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty Start of enrollment: 2015 Aug 31
Publications & Presentations
PubMed
- Timing of onset of menses after GnRH agonist treatment for central precocious puberty.Karen O Klein, Marcela Vargas Trujillo, Sanja Dragnic, Stephen Van Komen, Moming Li
Journal of Pediatric Endocrinology & Metabolism. 2024-08-27 - Treatment of Central Precocious Puberty with a Focus on Girls.Kanthi Bangalore Krishna, Karen O Klein, Erica A Eugster
Endocrinology and Metabolism Clinics of North America. 2024-06-01 - Timing of onset of menses after GnRH agonist treatment for central precocious puberty.Karen O Klein, Marcela Vargas Trujillo, Sanja Dragnic, Stephen Van Komen, Moming Li
Journal of Pediatric Endocrinology & Metabolism. 2024-05-27
Press Mentions
- Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur(TM), Triptorelin 6-Month Formulation, FoMay 1st, 2018
- FDA: Triptorelin Slows Central Precocious PubertyJuly 10th, 2017
- FDA Approves Triptodur for Treatment of Early PubertyJune 30th, 2017
Grant Support
- Recombinant Tissue Plasminogen Activator For Treatment Of Livedoid VasculitisNational Center For Research Resources1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: